NCT02137239 - Regimen Optimization Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions

Kidney Transplantation

Interventions

DRUG

Thymoglobulin

DRUG

Belatacept

DRUG

mycophenolate mofetil(MMF)

DRUG

Corticosteroids

DRUG

Everolimus(EVL)

DRUG

Tacrolimus(TAC)

Trial Locations (20)

2000

Sanatorio Parque S.A., Rosario

3000

Clinica De Nefrologia, Urologia Y Enf. Cardiovasculares, Sante Fe

5016

Clinica Privada Velez Sarsfield, Córdoba

14215

Erie County Medical Center, Buffalo

17104

Central PA Transplant Foundation, Harrisburg

20007

MedStar Georgetown University Hospital, Washington D.C.

22042

Inova Fairfax Hospital, Falls Church

27157

Wake Forest University School Of Medicine, Winston-Salem

30322

Emory Univeristy, Atlanta

37232

Vanderbilt University Medical Center, Nashville

60612

University Of Illinois, Chicago

70112

Tulane Medical Center, New Orleans

80045

University Of Colorado, Aurora

92123

California Institute Of Renal Research, San Diego

94115

California Pacific Medical Center, San Francisco

98104

Swedish Medical Center - Swedish Colon and Rectal Clinic - First Hill (Northwest Colon and Rectal Cl, Seattle

06519

Yale University, New Haven

02114

Massachusetts General Hospital, Boston

07039

Saint Barnabas Medical Center, Livingston

22908-0709

University of Virginia, Charlottesville